Alinaghi, F., Calov, M., Kristensen, L. E., Gladman, D. D., Coates, L. C., Jullien, D., Gottlieb, A. B., Gisondi, P., Wu, J. J., Thyssen, J. P., & Egeberg, A. (2019). Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. Journal of the American Academy of Dermatology, 80(251–265), e19.
Aylward, M., & Maddock, J. (1974). Proceedings: Plasma L-tryptophan concentrations in chronic rheumatic diseases and the effects of some antirheumatic drugs on the binding of the amino-acid to plasma proteins in vivo and in vitro. Rheumatology and Rehabilitation, 13, 62–74.
Bertazzo, A., Punzi, L., Bertazzolo, N., Pianon, M., Pozzuoli, A., Costa, C. V., & Allegri, G. (1999). Tryptophan catabolism in synovial fluid of various arthropathies and its relationship with inflammatory cytokines. Advances in Experimental Medicine and Biology, 467, 565–570.
Burger, B., Sagiorato, R. N., Cavenaghi, I., & Rodrigues, H. G. (2023). Abnormalities of sphingolipids metabolic pathways in the pathogenesis of psoriasis. Metabolites, 13, 291.
Caspi, R., Billington, R., Ferrer, L., Foerster, H., Fulcher, C. A., Keseler, I. M., Kothari, A., Krummenacker, M., Latendresse, M., Mueller, L. A., Ong, Q., Paley, S., Subhraveti, P., Weaver, D. S., & Karp, P. D. (2016). The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Research, 44, D471–D480.
Castaldo, G., Pagano, I., Grimaldi, M., Marino, C., Molettieri, P., Santoro, A., Stillitano, I., Romano, R., Montoro, P., D’Ursi, A. M., & Rastrelli, L. (2020). Effect of very-low-calorie ketogenic diet on psoriasis patients: A nuclear magnetic resonance-based metabolomic study. Journal of Proteome Research., 20, 1509.
Chakraborty, M., & Jiang, X. C. (2013). Sphingomyelin and its role in cellular signaling. Advances in Experimental Medicine and Biology, 991, 1–14.
Chandran, V. (2020). Pathway to biomarker discovery in psoriatic arthritis. Expert Review of Clinical Immunology, 16, 471–478.
Coras, R., Kavanaugh, A., Kluzniak, A., Holt, D., Weilgosz, A., Aaron, A., Quehenberger, O., Ritchlin, C., & Guma, M. (2021). Differences in oxylipin profile in psoriasis versus psoriatic arthritis. Arthritis Research & Therapy, 23, 200.
Duranton, F., Cohen, G., De Smet, R., Rodriguez, M., Jankowski, J., Vanholder, R., Argiles, A., European Uremic Toxin Work G. (2012). Normal and pathologic concentrations of uremic toxins. Journal of the American Society of Nephrology, 23, 1258–1270.
Emwas, A. H. (2015). The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Methods in Molecular Biology, 1277, 161–193.
Fan, S., Kind, T., Cajka, T., Hazen, S. L., Tang, W. H. W., Kaddurah-Daouk, R., Irvin, M. R., Arnett, D. K., Barupal, D. K., & Fiehn, O. (2019). Systematic error removal using random forest for normalizing large-scale untargeted lipidomics data. Analytical Chemistry, 91, 3590–3596.
FitzGerald, O., & Gladman, D. D. (2018). Oxford textbook of psoriatic arthritis (p. 1). Oxford University Press.
Haroon, M., Gallagher, P., & FitzGerald, O. (2015). Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Annals of the Rheumatic Diseases, 74, 1045–1050.
Helliwell, P. S., FitzGerald, O., Fransen, J., Gladman, D. D., Kreuger, G. G., Callis-Duffin, K., McHugh, N., Mease, P. J., Strand, V., Waxman, R., Azevedo, V. F., Beltran Ostos, A., Carneiro, S., Cauli, A., Espinoza, L. R., Flynn, J. A., Hassan, N., Healy, P., Kerzberg, E. M., … Walsh, J. A. (2013). The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Annals of the Rheumatic Diseases, 72, 986–991.
Jiang, H., Liu, J., Wang, T., Gao, J. R., Sun, Y., Huang, C. B., Meng, M., & Qin, X. J. (2016). Urinary metabolite profiling provides potential differentiation to explore the mechanisms of adjuvant-induced arthritis in rats. Biomedical Chromatography, 30, 1397–1405.
Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., & Morishima, K. (2017). KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Research, 45, D353–D361.
Kapoor, S. R., Filer, A., Fitzpatrick, M. A., Fisher, B. A., Taylor, P. C., Buckley, C. D., McInnes, I. B., Raza, K., & Young, S. P. (2013). Metabolic profiling predicts response to anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis. Arthritis and Rheumatism, 65, 1448–1456.
Koussiouris, J., Looby, N., Anderson, M., Kulasingam, V., & Chandran, V. (2021). Metabolomics studies in psoriatic disease: A review. Metabolites, 11, 375.
Lebwohl, M. G., Bachelez, H., Barker, J., Girolomoni, G., Kavanaugh, A., Langley, R. G., Paul, C. F., Puig, L., Reich, K., & van de Kerkhof, P. C. (2014). Patient perspectives in the management of psoriasis: Results from the population-based multinational assessment of psoriasis and psoriatic arthritis survey. Journal of the American Academy of Dermatology, 70(871–81), e1-30.
Li, S. S., Liu, Y., Li, H., Wang, L. P., Xue, L. F., Yin, G. S., & Wu, X. S. (2019). Identification of psoriasis vulgaris biomarkers in human plasma by non-targeted metabolomics based on UPLC-Q-TOF/MS. European Review for Medical and Pharmacological Sciences, 23, 3940–3950.
Liu, J. W., Murtada, K., Reyes-Garces, N., & Pawliszyn, J. (2020). Systematic evaluation of different coating chemistries used in thin-film microextraction. Molecules, 25, 3448.
Looby, N., Roszkowska, A., Reyes-Garces, N., Yu, M., Baczek, T., Kulasingam, V., Pawliszyn, J., & Chandran, V. (2021). Serum metabolic fingerprinting of psoriasis and psoriatic arthritis patients using solid-phase microextraction-liquid chromatography-high-resolution mass spectrometry. Metabolomics, 17, 59.
Mirnaghi, F. S., & Pawliszyn, J. (2012). Development of coatings for automated 96-blade solid phase microextraction-liquid chromatography-tandem mass spectrometry system, capable of extracting a wide polarity range of analytes from biological fluids. Journal of Chromatography A, 1261, 91–98.
N-RA, L. (2015). Verification: Weather forecast verification utilities [Internet]. https://cran.r-project.org/package=verification
Ottas, A., Fishman, D., Okas, T. L., Kingo, K., & Soomets, U. (2017). The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease. Archives of Dermatological Research, 309, 519–528.
Perruccio, A. V., Got, M., Li, S., Ye, Y., Gladman, D. D., & Chandran, V. (2020). Treating psoriatic arthritis to target: Defining the psoriatic arthritis disease activity score that reflects a state of minimal disease activity. Journal of Rheumatology, 47, 362–368.
Psychogios, N., Hau, D. D., Peng, J., Guo, A. C., Mandal, R., Bouatra, S., Sinelnikov, I., Krishnamurthy, R., Eisner, R., Gautam, B., Young, N., Xia, J., Knox, C., Dong, E., Huang, P., Hollander, Z., Pedersen, T. L., Smith, S. R., Bamforth, F., … Wishart, D. S. (2011). The human serum metabolome. PLoS ONE, 6, e16957.
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J. C., & Muller, M. (2011). pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics, 12, 77.
Sorgdrager, F. J. H., Naude, P. J. W., Kema, I. P., Nollen, E. A., & Deyn, P. P. (2019). Tryptophan metabolism in inflammaging: From biomarker to therapeutic target. Frontiers in Immunology, 10, 2565.
Tsugawa, H., Cajka, T., Kind, T., Ma, Y., Higgins, B., Ikeda, K., Kanazawa, M., VanderGheynst, J., Fiehn, O., & Arita, M. (2015). MS-DIAL: Data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nature Methods, 12, 523–526.
van der Heijde, D., Gladman, D. D., Kavanaugh, A., & Mease, P. J. (2020). Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research. Arthritis Research & Therapy, 22, 18.
Vuckovic, D. (2012). Current trends and challenges in sample preparation for global metabolomics using liquid chromatography–mass spectrometry. Analytical and Bioanalytical Chemistry, 403, 1523–1548.
Vuckovic, D. (2013). High-throughput solid-phase microextraction in multi-well-plate format. TrAC Trends in Analytical Chemistry, 45, 136–153.
Wang, M., Carver, J. J., Phelan, V. V., Sanchez, L. M., Garg, N., Peng, Y., Nguyen, D. D., Watrous, J., Kapono, C. A., Luzzatto-Knaan, T., Porto, C., Bouslimani, A., Melnik, A. V., Meehan, M. J., Liu, W. T., Crusemann, M., Boudreau, P. D., Esquenazi, E., Sandoval-Calderon, M., … Phapale, P. (2016). Sharing and community curation of mass spectrometry data with global natural products social molecular networking. Nature Biotechnology, 34, 828–837.
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., Fung, C., Nikolai, L., Lewis, M., Coutouly, M. A., Forsythe, I., Tang, P., Shrivastava, S., Jeroncic, K., Stothard, P., … Querengesser, L. (2007). HMDB: The human metabolome database. Nucleic Acids Research, 35, D521–D526.
Yang, K. L., Lejeune, A., Chang, G., Scher, J. U., & Koralov, S. B. (2021). Microbial-derived antigens and metabolites in spondyloarthritis. Semin Immunopathol, 43, 163–172.
Zeng, C., Wen, B., Hou, G., Lei, L., Mei, Z., Jia, X., Chen, X., Zhu, W., Li, J., Kuang, Y., Zeng, W., Su, J., Liu, S., Peng, C., & Chen, X. (2017). Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis. GigaScience, 6, 1–11.
Zhai, G., Randell, E. W., & Rahman, P. (2018). Metabolomics of osteoarthritis: Emerging novel markers and their potential clinical utility. Rheumatology, 57, 2087–2095.
Zhao, H., Lazarenko, O. P., & Chen, J. R. (2020). Hippuric acid and 3-(3-hydroxyphenyl) propionic acid inhibit murine osteoclastogenesis through RANKL-RANK independent pathway. Journal of Cellular Physiology, 235, 599–610.
